David Mai

899 citations
15 papers · 549 · 1 hit paper · h-index 8

Impact in

    • CAR-T cell therapy research
    • Nanoplatforms for cancer theranostics
    • Characterization and Applications of Magnetic Nanoparticles
    • Nanowire Synthesis and Applications

Papers in

    • CAR-T cell therapy research 8
    • Nanowire Synthesis and Applications 3
    • Characterization and Applications of Magnetic Nanoparticles 2

David Mai

14 papers receiving 544 citations

David Mai's Hit Papers

Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering 2023 · 66 citations
660+1+2Years since publication204060

Peers

David Mai
Comparison fields: 5 of 76
  • Oncology 198
  • Biomedical Engineering 265
  • Immunology 126
  • Biomaterials 67
  • Molecular Biology 270
Replace Hongliang Fang with:
Hongliang Fang China
Xiaoyang Zhang China
Feifei Qi China
Zachary Spencer Dunn United States
James Wang United States
Spencer K. Tumbale United States
Mubin Tarannum United States
Nikita Subedi Netherlands
Xiandi Meng China
Lujia Huang China
David Mai relative to Hongliang Fang China Hongliang Fang's profile →
Citations per field
00.5×11×
Hongliang Fang · 1×
Citations per year

Countries citing papers authored by David Mai

Since Specialization
Citations

This map shows the geographic impact of David Mai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mai more than expected).

Fields of papers citing papers by David Mai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Mai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mai. The network helps show where David Mai may publish in the future.

Co-authors

The 25 scholars most cited alongside David Mai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Mai Line = papers co-authored together David Mai links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 2021133
2 2023109
3 201877
4
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
Hit paper breakdown →
202366
5 202351
6 202448
7 202132
8 202223
9 20252
10
Urban Cycling Expansion is Associated with an Increased Number of Clavicle Fractures.
20202
11 20222
12 20212
13 20241
14 20241
15 20240

About David Mai

David Mai is a scholar working on Oncology, Biomedical Engineering, Molecular Biology, Genetics and Immunology, having authored 15 papers that have together received 549 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Nanowire Synthesis and Applications (3 papers), Virus-based gene therapy research (3 papers), RNA Interference and Gene Delivery (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Characterization and Applications of Magnetic Nanoparticles (2 papers), Immune Cell Function and Interaction (2 papers) and Spine and Intervertebral Disc Pathology (1 paper). The work is most often cited by research in Oncology (198 citations), Biomedical Engineering (265 citations), Immunology (126 citations), Biomaterials (67 citations) and Molecular Biology (270 citations). David Mai has collaborated with scholars based in United States and Russia. Frequent co-authors include Neil C. Sheppard, Carl H. June, Michael J. Mitchell, Alex G. Hamilton, Margaret M. Billingsley, Kelsey L. Swingle, Ningqiang Gong, Savan K. Patel, Ajay S. Thatte and Xuexiang Han. Their work appears in journals such as Nano Letters, Scientific Reports, ACS Synthetic Biology, The Journal of Physical Chemistry C and Advanced Healthcare Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact